Abstract

Lipoprotein lipase (LPL) is a central enzyme in lipoprotein metabolism and is expressed predominantly in adipose tissue and muscle. In these tissues, the regulation of LPL is complex and often opposite in response to the same physiologic stimulus. In addition, much regulation of LPL occurs post-transcriptionally. The human LPL cDNA is characterized by a long 3'-untranslated region, which has two polyadenylation signals. In this report, human adipose tissue expressed two LPL mRNA species (3.2 and 3.6 kb) due to an apparent random choice of sites for mRNA polyadenylation, whereas human skeletal and heart muscle expressed predominantly the longer 3.6-kb mRNA form. To determine whether there was any functional significance to this tissue-specific mRNA expression, poly(A)-enriched RNA from adipose tissue and muscle were translated in vitro, and the poly(A)-enriched RNA from muscle was more efficiently translated into LPL protein. The increased translatability of the 3.6-kb form was also demonstrated by cloning the full-length 3.2- and 3.6-kb LPL cDNA forms, followed by in vitro translation of in vitro prepared transcripts. To confirm that this increased efficiency of translation occurred in vivo, Chinese hamster ovary cells were transfected with the 3.2- and 3.6-kb LPL cDNAs. Cells transfected with the 3.6-kb construct demonstrated increased LPL activity and synthesis, despite no increase in levels of LPL mRNA. Thus, human muscle expresses the 3.6-kb form of LPL due to a non-random choice of polyadenylation signals, and this form is more efficiently translated than the 3.2-kb form.

Highlights

  • Lipoprotein lipase (LPL) is a central enzyme in lipoprotein metabolism and is expressed predominantly in adipose tissue and muscle

  • The human LPL cDNA is characterized by a long 3'-untranslated region, which has two polyadenylation signals

  • To determine whether there was any functional significance to this tissue-specific mRNA expression, poly(A)-enriched RNA from adipose tissue and muscle were translated in vitro, and the poly(A)-enriched RNA from muscle was more efficiently translated into LPL protein

Read more

Summary

THE JOURNAL OF BIOLOGICAL CHEMISTRY

Vol 270, No 13, Issue of March 31, pp. 7149-7155, 1995 Printed in U.S.A. (Received for publication, August 29, 1994, and in revised form, December 2, 1994). Human adipose tissue expressed two LPL mRNA species (3.2 and 3.6 kb) due to an apparent random choice of sites for mRNA polyadenylation, whereas human skeletal and heart muscle expressed predominantly the longer 3.6-kb mRNA form. ~ To whom correspondence should be addressed: Division of Endocrinology, Becker 131, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA 90048. The human LPL eDNA sequence is known and is characterized by a 2-kb 3'-untranslated region (UTR), with two consensus sequences for addition of the poly(A) tail [18] If these polyadenylation sites were used randomly during post-transcriptional modification of the primary LPL RNA transcript, one would expect to detect the presence of two LPL mRNA species upon Northern blotting. We examined the tissue-specific expression of LPL mRNA from human adipose tissue and compared it with human skeletal and cardiac muscle

MATERIALS AND METHODS
RES ULTS
Sk I t I Muscle
LPL mANA"
Ad ip ose Tis sue
DIS C US SI ON
Med ium
REFERENCE S
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call